This Week’s Pharma News Roundup Geared for Success
The Pharma industry is non-stop on the go, generating news and updates that cannot be overlooked by professionals. We want you to succeed and stay ahead of the game. With that in mind, we have hand-picked relevant articles from some of the top Pharmaceutical publications for you to review or simply store in your library for extra reading.
Enjoy our selection of this week’s Pharma news articles.
1. A Digital Revolution for Patient Care
by Sunil Rao, published on PharmaPhorum
Sunil Rao discusses the positive impact of digital technologies on patient care. Read on to find out how digital maturity of life sciences companies will allow the industry to personalize therapeutic approaches, interact and engage with patients, and optimize products and services that ultimately improve health outcomes while saving costs.
2. How to Find — and Hire — Data Scientists
by John Koetsier, published on Venture Beat
Roughly 140,000 people are employed as data scientists today. By 2018, the market will need 440,000 to 490,000 professionals. According to Pete Skomoroch, former principal data scientist at LinkedIn, “there are up to 250,000 people in the workforce today with the talent and ability to be data scientists,”. Where do you find these individuals for hire? View this article to get a scoop on how to find the perfect match for your team.
3. Pharma Rep Access Down 33 Per Cent Since 2008
by PharmaExec, published on PharmaExec Blog
A 33% steady decline since 2008 – This astonishing number in rep access to physicians is disconcerting. Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year with about half (49 percent) of physicians in the U.S. placing moderate-to-severe restrictions on visits in 2014. View the findings as well as tips on how to communicate through physician’s preferred channels.
4. Scapegoating the Pharmaceutical Industry Will Not Solve the Healthcare Crisis and Might Even Make It Worse
by Justin McGinnis, published on Forbes
“A study by the OECD found that the U.S spends 152% more on pharmaceuticals than the average OECD country. Disturbing statistic isn’t it?” Justin McGinnis further presents the ramifications of focusing criticism solely on the Pharmaceutical industry. Read this article to discover how “the worst choice of scapegoat” will not solve the healthcare crisis but only distract from larger issues.
5. Moving to Specialty Drugs: Are You on Track?
by Greg Barlow, published on Verix Blog
Over the next five years, specialty drugs are expected to be the biggest drivers of branded drug spend growth, with investment projecting to increase 30%. Why is that? How can you leverage this trend? In this free white paper, we review industry trends, hurdles to entry, impact to commercialization strategies and analysis tips. Are you ready to make the move to specialty medicines? View this article today to see if you are truly ready to make the move.
